Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Gray

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
Scientific Reports|January 14, 2016
Promotion of a cancer-like phenotype, through chronic exposure to inflammatory cytokines and hypoxia in a bronchial epithelial cell line modelAnne-Marie Baird, Steven G Gray, Derek J Richard, et al.
Epigenomics|October 20, 2015
VEGF-mediated cell survival in non-small-cell lung cancer: implications for epigenetic targeting of VEGF receptors as a therapeutic approachMartin P Barr, Kenneth J O'Byrne, Nael Al-Sarraf, et al.
Expert Opinion on Therapeutic Targets|June 30, 2016
The IL-17-Th1/Th17 pathway: an attractive target for lung cancer therapy?Markus Joerger, Stephen P Finn, Sinead Cuffe, et al.
Oncoscience|July 24, 2018
The therapeutic properties of resminostat for hepatocellular carcinomaJun Zhao, Steven G Gray, Martin Wabitsch, et al.
Journal of Cellular and Molecular Medicine|May 15, 2009
NF-kappaB regulation: the nuclear responseArun K Mankan, Matthew W Lawless, Steven G Gray, et al.
Journal of Agricultural and Food Chemistry|July 28, 2017
Extraction and Quantification of Sinapinic Acid from Irish Rapeseed Meal and Assessment of Angiotensin-I Converting Enzyme (ACE-I) Inhibitory ActivityLeah Quinn, Steven G Gray, Steve Meaney, et al.
International Journal of Oncology|February 13, 2003
Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrateIrina Svechnikova, Steven G Gray, Jurgita Kundrotiene, et al.
Pigment Cell & Melanoma Research|February 16, 2011
Receptor tyrosine kinases and their activation in melanomaDavid J Easty, Steven G Gray, Kenneth J O'Byrne, et al.
Cancers|March 29, 2023
Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung CancerÉabha O'Sullivan, Anna Keogh, Brian Henderson, et al.
Oncology Reports|July 26, 2006
Histone deacetylase 3 represses HTLV-1 tax transcriptionRaul Villanueva, Antonio H Iglesias, Sandra Camelo, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Scientific Reports|January 14, 2016
Promotion of a cancer-like phenotype, through chronic exposure to inflammatory cytokines and hypoxia in a bronchial epithelial cell line modelAnne-Marie Baird, Steven G Gray, Derek J Richard, et al.
Epigenomics|October 20, 2015
VEGF-mediated cell survival in non-small-cell lung cancer: implications for epigenetic targeting of VEGF receptors as a therapeutic approachMartin P Barr, Kenneth J O'Byrne, Nael Al-Sarraf, et al.
Expert Opinion on Therapeutic Targets|June 30, 2016
The IL-17-Th1/Th17 pathway: an attractive target for lung cancer therapy?Markus Joerger, Stephen P Finn, Sinead Cuffe, et al.
Oncoscience|July 24, 2018
The therapeutic properties of resminostat for hepatocellular carcinomaJun Zhao, Steven G Gray, Martin Wabitsch, et al.
Journal of Cellular and Molecular Medicine|May 15, 2009
NF-kappaB regulation: the nuclear responseArun K Mankan, Matthew W Lawless, Steven G Gray, et al.
Journal of Agricultural and Food Chemistry|July 28, 2017
Extraction and Quantification of Sinapinic Acid from Irish Rapeseed Meal and Assessment of Angiotensin-I Converting Enzyme (ACE-I) Inhibitory ActivityLeah Quinn, Steven G Gray, Steve Meaney, et al.
International Journal of Oncology|February 13, 2003
Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrateIrina Svechnikova, Steven G Gray, Jurgita Kundrotiene, et al.
Pigment Cell & Melanoma Research|February 16, 2011
Receptor tyrosine kinases and their activation in melanomaDavid J Easty, Steven G Gray, Kenneth J O'Byrne, et al.
Cancers|March 29, 2023
Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung CancerÉabha O'Sullivan, Anna Keogh, Brian Henderson, et al.
Oncology Reports|July 26, 2006
Histone deacetylase 3 represses HTLV-1 tax transcriptionRaul Villanueva, Antonio H Iglesias, Sandra Camelo, et al.
Pageof 11